Literature DB >> 15272116

"siRNAs and miRNAs": a meeting report on RNA silencing.

Zhengying He1, Erik J Sontheimer.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15272116      PMCID： PMC1370606          DOI： 10.1261/rna.7900204

Source DB:  PubMed          Journal:  RNA        ISSN： 1355-8382            Impact factor:   4.942


× No keyword cloud information.
  57 in total

1.  RNA interference is mediated by 21- and 22-nucleotide RNAs.

Authors:  S M Elbashir; W Lendeckel; T Tuschl
Journal:  Genes Dev       Date:  2001-01-15       Impact factor: 11.361

Review 2.  Quelling in Neurospora crassa.

Authors:  Annette S Pickford; Caterina Catalanotto; Carlo Cogoni; Giuseppe Macino
Journal:  Adv Genet       Date:  2002       Impact factor: 1.944

3.  The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans.

Authors:  B J Reinhart; F J Slack; M Basson; A E Pasquinelli; J C Bettinger; A E Rougvie; H R Horvitz; G Ruvkun
Journal:  Nature       Date:  2000-02-24       Impact factor: 49.962

4.  The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation.

Authors:  P H Olsen; V Ambros
Journal:  Dev Biol       Date:  1999-12-15       Impact factor: 3.582

Review 5.  Pattern formation during C. elegans vulval induction.

Authors:  M Wang; P W Sternberg
Journal:  Curr Top Dev Biol       Date:  2001       Impact factor: 4.897

6.  Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization.

Authors:  J Cavaillé; K Buiting; M Kiefmann; M Lalande; C I Brannan; B Horsthemke; J P Bachellerie; J Brosius; A Hüttenhofer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

7.  Role for a bidentate ribonuclease in the initiation step of RNA interference.

Authors:  E Bernstein; A A Caudy; S M Hammond; G J Hannon
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

8.  Mut-7 of C. elegans, required for transposon silencing and RNA interference, is a homolog of Werner syndrome helicase and RNaseD.

Authors:  R F Ketting; T H Haverkamp; H G van Luenen; R H Plasterk
Journal:  Cell       Date:  1999-10-15       Impact factor: 41.582

9.  Crystallographic and modeling studies of RNase III suggest a mechanism for double-stranded RNA cleavage.

Authors:  J Blaszczyk; J E Tropea; M Bubunenko; K M Routzahn; D S Waugh; D L Court; X Ji
Journal:  Structure       Date:  2001-12       Impact factor: 5.006

10.  The lin-41 RBCC gene acts in the C. elegans heterochronic pathway between the let-7 regulatory RNA and the LIN-29 transcription factor.

Authors:  F J Slack; M Basson; Z Liu; V Ambros; H R Horvitz; G Ruvkun
Journal:  Mol Cell       Date:  2000-04       Impact factor: 17.970
View more
  4 in total

1.  EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3.

Authors:  Tianli Xia; Andrea O'Hara; Iguaracyra Araujo; Jose Barreto; Eny Carvalho; Jose Bahia Sapucaia; Juan Carlos Ramos; Estela Luz; Celia Pedroso; Michele Manrique; Ngoc L Toomey; Carlos Brites; Dirk P Dittmer; William J Harrington
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

2.  MicroInspector: a web tool for detection of miRNA binding sites in an RNA sequence.

Authors:  Ventsislav Rusinov; Vesselin Baev; Ivan Nikiforov Minkov; Martin Tabler
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

3.  A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites.

Authors:  Quan Du; Håkan Thonberg; Jue Wang; Claes Wahlestedt; Zicai Liang
Journal:  Nucleic Acids Res       Date:  2005-03-21       Impact factor: 16.971

4.  Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAs.

Authors:  Huang Huang; Renping Qiao; Deyao Zhao; Tong Zhang; Youxian Li; Fan Yi; Fangfang Lai; Junmei Hong; Xianfeng Ding; Zhenjun Yang; Lihe Zhang; Quan Du; Zicai Liang
Journal:  Nucleic Acids Res       Date:  2009-12       Impact factor: 16.971
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.